Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Perantoni Website

Alan O. Perantoni, Ph.D.

Selected Publications
1)  Boyle S, Shioda T, Perantoni AO, de Caestecker M.
Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis.
Dev. Dyn. 236: 2321-30, 2007. [Journal]
2)  Lovvorn HN, Westrup J, Opperman S, Boyle S, Shi G, Anderson J, Perlman EJ, Perantoni AO, Wills M, de Caestecker M.
CITED1 expression in Wilms' tumor and embryonic kidney.
Neoplasia. 9: 589-600, 2007. [Journal]
3)  Levashova ZB, Sharma N, Timofeeva OA, Dome JS, Perantoni AO.
ELR+-CXC chemokines and their receptors in early metanephric development.
J. Am. Soc. Nephrol. 18: 2359-70, 2007. [Journal]
4)  Kim HS, Kim MS, Hancock AL, Harper JC, Park JY, Poy G, Perantoni AO, Cam M, Malik K, Lee SB.
Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development.
J Biol Chem. 282: 16278-16287, 2007. [Journal]
5)  Timofeeva OA, Gaponenko V, Lockett SJ, Tarasov SG, Jiang S, Michejda CJ, Perantoni AO, Tarasova NI.
Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target.
ACS Chem. Biol. 2: 799-809, 2007. [Journal]
6)  Lovvorn HN, Boyle S, Shi G, Shyr Y, Wills ML, Perantoni AO, de Caestecker M.
Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1.
J. Pediatr. Surg. 42: 474-81, 2007. [Journal]
7)  Perantoni AO. McKinnell RG, Parchment RE, Perantoni AO, Pierce GB, eds.
Cancer-associated genes. In: The Biological Basis of Cancer. Volume .
New York: Cambridge University Press; 2006. p. 145-194 [Book Chapter]
8)  Perantoni AO. McKinnell RG, Parchment RE, Perantoni AO, Pierce GB, eds.
Carcinogenesis. In: The Biological Basis of Cancer. Volume .
New York: Cambridge University Press; 2006. p. 80-125 [Book Chapter]
9)  Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS, Perantoni AO.
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis.
Oncogene. 25: 7555-64, 2006. [Journal]
10)  Plisov S, Tsang M, Shi G, Boyle S, Yoshino K, Dunwoodie SL, Dawid IB, Shioda T, Perantoni AO, de Caestecker MP.
Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning.
J Am Soc Nephrol. 16: 1632-44, 2005. [Journal]
11)  Perantoni AO, Timofeeva O, Naillat F, Richman C, Pajni-Underwood S, Wilson C, Vainio S, Dove LF, Lewandoski M.
Inactivation of Fgf8 in early mesoderm reveals an essential role in nephron development.
Development. 132: 3859-3871, 2005. [Journal]
12)  Chen B, Blair DG, Plisov S, Vasiliev G, Perantoni AO, Chen Q, Athanasiou M, Wu JY, Oppenheim JJ, Yang D.
Cutting edge: bone morphogenetic protein antagonists drm/gremlin and dan interact with slits and act as negative regulators of monocyte chemotaxis.
J Immunol. 173: 5914-7, 2004. [Journal]
13)  Perantoni AO. Sell S, eds.
Nephroblastoma: A metanephric caricature. In: The Stem Cell Handbook. Volume .
Totowa, NJ: Humana Press; 2003. p. 277-88 [Book Chapter]
14)  Levashova ZB, Plisov SY, Perantoni AO.
Conditionally immortalized cell line of inducible metanephric mesenchyme.
Kidney Int. 63: 2075-87, 2003. [Journal]
15)  Perantoni AO.
Renal development: perspectives on a Wnt-dependent process.
Semin. Cell Dev. Biol. 14: 201-8, 2003. [Journal]
16)  Perantoni AO.
The ureteric bud. Tissue-culture approaches to branching morphogenesis and inductive signaling.
Methods Mol. Med. 86: 179-92, 2003. [Journal]
17)  Zhang F, Nakanishi G, Kurebayashi S, Yoshino K, Perantoni A, Kim YS, Jetten AM.
Characterization of Glis2, a novel gene encoding a Gli-related, Kruppel-like transcription factor with transactivation and repressor functions. Roles in kidney development and neurogenesis.
J Biol Chem. 277: 10139-49, 2002. [Journal]
18)  Shiao YH, Ramakrishna G, Anderson LM, Perantoni AO, Rice JM, Diwan BA.
Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors.
Cancer Lett. 179: 33-8, 2002. [Journal]
19)  Muramatsu Y, Tsujie M, Kohda Y, Pham B, Perantoni AO, Zhao H, Jo SK, Yuen PS, Craig L, Hu X, Star RA.
Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury.
Kidney Int. 62: 1601-10, 2002. [Journal]
20)  Kim YS, Lewandoski M, Perantoni AO, Kurebayashi S, Nakanishi G, Jetten AM.
Identification of Glis1, a novel Gli-related, Kruppel-like zinc finger protein containing transactivation and repressor functions.
J Biol Chem. 277: 30901-13, 2002. [Journal]
21)  Yoshino K, Rubin JS, Higinbotham KG, Uren A, Anest V, Plisov SY, Perantoni AO.
Secreted Frizzled-related proteins can regulate metanephric development.
Mech Dev. 102: 45-55, 2001. [Journal]
22)  Plisov SY, Yoshino K, Dove LF, Higinbotham KG, Rubin JS, Perantoni AO.
TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis.
Development. 128: 1045-57, 2001. [Journal]
23)  Plisov SY, Ivanov SV, Yoshino K, Dove LF, Plisova TM, Higinbotham KG, Karavanova I, Lerman M, Perantoni AO.
Mesenchymal-epithelial transition in the developing metanephric kidney: gene expression study by differential display.
Genesis. 27: 22-31, 2000. [Journal]

This page was last updated on 11/24/2008.